nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS2—Dexamethasone—ankylosing spondylitis	0.199	0.259	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—ankylosing spondylitis	0.0702	0.0912	CbGbCtD
Doxorubicin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.05	0.065	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—ankylosing spondylitis	0.0475	0.0617	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0475	0.0617	CbGbCtD
Doxorubicin—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0452	0.0588	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—ankylosing spondylitis	0.0441	0.0574	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—ankylosing spondylitis	0.0271	0.0352	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—ankylosing spondylitis	0.025	0.0324	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—ankylosing spondylitis	0.0226	0.0293	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0215	0.028	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—ankylosing spondylitis	0.0201	0.0261	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—ankylosing spondylitis	0.0181	0.0236	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0159	0.0206	CbGbCtD
Doxorubicin—ABCB1—Betamethasone—ankylosing spondylitis	0.014	0.0182	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—ankylosing spondylitis	0.0138	0.0179	CbGbCtD
Doxorubicin—ABCB1—Prednisone—ankylosing spondylitis	0.013	0.0169	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0129	0.0168	CbGbCtD
Doxorubicin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00977	0.0127	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—ankylosing spondylitis	0.00838	0.0109	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—ankylosing spondylitis	0.00827	0.0108	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—ankylosing spondylitis	0.00814	0.0106	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—ankylosing spondylitis	0.00781	0.0102	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00767	0.00997	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—ankylosing spondylitis	0.00654	0.0085	CbGbCtD
Doxorubicin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00488	0.00634	CbGbCtD
Doxorubicin—NOS2—tendon—ankylosing spondylitis	0.000399	0.15	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—ankylosing spondylitis	0.00037	0.057	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—ankylosing spondylitis	0.000364	0.0561	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—ankylosing spondylitis	0.000364	0.0561	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—ankylosing spondylitis	0.000356	0.0548	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisone—ankylosing spondylitis	0.000337	0.052	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—ankylosing spondylitis	0.000329	0.0508	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.000305	0.0471	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—ankylosing spondylitis	0.000301	0.0464	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.000301	0.0464	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	0.000281	0.0433	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—ankylosing spondylitis	0.000279	0.043	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	0.000276	0.0426	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	0.000276	0.0426	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—ankylosing spondylitis	0.000272	0.042	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	0.00027	0.0416	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	0.00025	0.0386	CbGdCrCtD
Doxorubicin—CBR3—tendon—ankylosing spondylitis	0.000248	0.0927	CbGeAlD
Doxorubicin—AKR1A1—tendon—ankylosing spondylitis	0.000191	0.0716	CbGeAlD
Doxorubicin—NDUFS7—tendon—ankylosing spondylitis	0.000174	0.0651	CbGeAlD
Doxorubicin—AURKA—tendon—ankylosing spondylitis	0.000162	0.0605	CbGeAlD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000151	0.0233	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000151	0.0233	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000149	0.0229	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000149	0.0229	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000145	0.0224	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000145	0.0224	CbGdCrCtD
Doxorubicin—NOS1—tendon—ankylosing spondylitis	0.000145	0.0543	CbGeAlD
Doxorubicin—NDUFS2—tendon—ankylosing spondylitis	0.000144	0.0539	CbGeAlD
Doxorubicin—NDUFS3—tendon—ankylosing spondylitis	0.000142	0.0533	CbGeAlD
Doxorubicin—CBR3—Betamethasone—Prednisone—ankylosing spondylitis	0.000138	0.0213	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—ankylosing spondylitis	0.000138	0.0213	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000135	0.0207	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—ankylosing spondylitis	0.000135	0.0207	CbGdCrCtD
Doxorubicin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000126	0.000569	CcSEcCtD
Doxorubicin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000126	0.000569	CcSEcCtD
Doxorubicin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000126	0.000569	CcSEcCtD
Doxorubicin—Epistaxis—Methotrexate—ankylosing spondylitis	0.000126	0.000568	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000126	0.000568	CcSEcCtD
Doxorubicin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000126	0.000568	CcSEcCtD
Doxorubicin—Mental disorder—Prednisone—ankylosing spondylitis	0.000126	0.000567	CcSEcCtD
Doxorubicin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000126	0.000567	CcSEcCtD
Doxorubicin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000125	0.000564	CcSEcCtD
Doxorubicin—Erythema—Prednisone—ankylosing spondylitis	0.000125	0.000563	CcSEcCtD
Doxorubicin—Malnutrition—Prednisone—ankylosing spondylitis	0.000125	0.000563	CcSEcCtD
Doxorubicin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000125	0.000563	CcSEcCtD
Doxorubicin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000125	0.000562	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000124	0.000561	CcSEcCtD
Doxorubicin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000124	0.000561	CcSEcCtD
Doxorubicin—Convulsion—Betamethasone—ankylosing spondylitis	0.000124	0.000561	CcSEcCtD
Doxorubicin—YWHAG—tendon—ankylosing spondylitis	0.000124	0.0464	CbGeAlD
Doxorubicin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000124	0.000559	CcSEcCtD
Doxorubicin—Hypertension—Betamethasone—ankylosing spondylitis	0.000124	0.000559	CcSEcCtD
Doxorubicin—Myalgia—Betamethasone—ankylosing spondylitis	0.000122	0.000551	CcSEcCtD
Doxorubicin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000122	0.000551	CcSEcCtD
Doxorubicin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000122	0.000549	CcSEcCtD
Doxorubicin—Anxiety—Betamethasone—ankylosing spondylitis	0.000122	0.000549	CcSEcCtD
Doxorubicin—Discomfort—Betamethasone—ankylosing spondylitis	0.000121	0.000544	CcSEcCtD
Doxorubicin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000121	0.000544	CcSEcCtD
Doxorubicin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00012	0.000544	CcSEcCtD
Doxorubicin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00012	0.000543	CcSEcCtD
Doxorubicin—Pain—Prednisolone—ankylosing spondylitis	0.00012	0.000541	CcSEcCtD
Doxorubicin—Hepatitis—Methotrexate—ankylosing spondylitis	0.00012	0.000541	CcSEcCtD
Doxorubicin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00012	0.000541	CcSEcCtD
Doxorubicin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000119	0.000537	CcSEcCtD
Doxorubicin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000118	0.000534	CcSEcCtD
Doxorubicin—Vision blurred—Prednisone—ankylosing spondylitis	0.000118	0.000531	CcSEcCtD
Doxorubicin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000117	0.00053	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000117	0.00053	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000117	0.000529	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—ankylosing spondylitis	0.000117	0.000528	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000117	0.000528	CcSEcCtD
Doxorubicin—Oedema—Betamethasone—ankylosing spondylitis	0.000117	0.000528	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000117	0.000528	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000117	0.000526	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000116	0.000525	CcSEcCtD
Doxorubicin—Infection—Betamethasone—ankylosing spondylitis	0.000116	0.000525	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—ankylosing spondylitis	0.000116	0.000525	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000116	0.000523	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000116	0.000523	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000116	0.000522	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000116	0.000521	CcSEcCtD
Doxorubicin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000116	0.000521	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—ankylosing spondylitis	0.000115	0.000521	CcSEcCtD
Doxorubicin—Shock—Betamethasone—ankylosing spondylitis	0.000115	0.00052	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—ankylosing spondylitis	0.000115	0.00052	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000115	0.000519	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000115	0.000518	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000115	0.000518	CcSEcCtD
Doxorubicin—Agitation—Prednisone—ankylosing spondylitis	0.000115	0.000518	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000115	0.000517	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000115	0.000517	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000114	0.000515	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000114	0.000515	CcSEcCtD
Doxorubicin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000114	0.000512	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000113	0.000511	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000113	0.000511	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000113	0.000511	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000113	0.000511	CcSEcCtD
Doxorubicin—Malaise—Prednisone—ankylosing spondylitis	0.000113	0.000508	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—ankylosing spondylitis	0.000112	0.000506	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000112	0.000506	CcSEcCtD
Doxorubicin—RALBP1—tendon—ankylosing spondylitis	0.000112	0.0419	CbGeAlD
Doxorubicin—Syncope—Prednisone—ankylosing spondylitis	0.000112	0.000505	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000112	0.000504	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000112	0.000503	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—ankylosing spondylitis	0.000112	0.000503	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—ankylosing spondylitis	0.000111	0.000503	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000111	0.000502	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000111	0.000502	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000111	0.000501	CcSEcCtD
Doxorubicin—Pain—Triamcinolone—ankylosing spondylitis	0.00011	0.000498	CcSEcCtD
Doxorubicin—NOS3—tendon—ankylosing spondylitis	0.00011	0.0413	CbGeAlD
Doxorubicin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00011	0.000495	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—ankylosing spondylitis	0.000109	0.000493	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000109	0.000493	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000109	0.000491	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000108	0.000489	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—ankylosing spondylitis	0.000108	0.000488	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000108	0.000488	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—ankylosing spondylitis	0.000108	0.000486	CcSEcCtD
Doxorubicin—Chills—Methotrexate—ankylosing spondylitis	0.000108	0.000485	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000107	0.000481	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000107	0.000481	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—ankylosing spondylitis	0.000106	0.00048	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—ankylosing spondylitis	0.000106	0.00048	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000106	0.00048	CcSEcCtD
Doxorubicin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000106	0.000479	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—ankylosing spondylitis	0.000106	0.000478	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—ankylosing spondylitis	0.000106	0.000478	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—ankylosing spondylitis	0.000106	0.000478	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000106	0.000478	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000106	0.000476	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000105	0.000475	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000105	0.000474	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000105	0.000474	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—ankylosing spondylitis	0.000105	0.000474	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000105	0.000474	CcSEcCtD
Doxorubicin—CBR1—tendon—ankylosing spondylitis	0.000105	0.0391	CbGeAlD
Doxorubicin—Erythema—Methotrexate—ankylosing spondylitis	0.000104	0.000471	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000104	0.000471	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000103	0.000466	CcSEcCtD
Doxorubicin—AKR1C3—tendon—ankylosing spondylitis	0.000103	0.0387	CbGeAlD
Doxorubicin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000103	0.000465	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000103	0.000465	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000102	0.000462	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000102	0.000461	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000102	0.000461	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000102	0.00046	CcSEcCtD
Doxorubicin—Oedema—Prednisone—ankylosing spondylitis	0.000102	0.00046	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000102	0.00046	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000102	0.000459	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000102	0.000459	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000102	0.000459	CcSEcCtD
Doxorubicin—Infection—Prednisone—ankylosing spondylitis	0.000101	0.000457	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000101	0.000456	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000101	0.000456	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—ankylosing spondylitis	0.000101	0.000456	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000101	0.000455	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—ankylosing spondylitis	0.000101	0.000455	CcSEcCtD
Doxorubicin—Shock—Prednisone—ankylosing spondylitis	0.0001	0.000452	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—ankylosing spondylitis	0.0001	0.000452	CcSEcCtD
Doxorubicin—Pain—Betamethasone—ankylosing spondylitis	0.0001	0.000452	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—ankylosing spondylitis	9.99e-05	0.000451	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—ankylosing spondylitis	9.95e-05	0.000449	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—ankylosing spondylitis	9.9e-05	0.000447	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.85e-05	0.000445	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—ankylosing spondylitis	9.83e-05	0.000444	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—ankylosing spondylitis	9.71e-05	0.000438	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	9.68e-05	0.000437	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—ankylosing spondylitis	9.64e-05	0.000435	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	9.64e-05	0.000435	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—ankylosing spondylitis	9.64e-05	0.000435	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.57e-05	0.000432	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.57e-05	0.000432	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.5e-05	0.000429	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.48e-05	0.000428	CcSEcCtD
Doxorubicin—POR—tendon—ankylosing spondylitis	9.43e-05	0.0353	CbGeAlD
Doxorubicin—Malaise—Methotrexate—ankylosing spondylitis	9.41e-05	0.000425	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—ankylosing spondylitis	9.37e-05	0.000423	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—ankylosing spondylitis	9.34e-05	0.000422	CcSEcCtD
Doxorubicin—Urticaria—Dexamethasone—ankylosing spondylitis	9.3e-05	0.00042	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—ankylosing spondylitis	9.3e-05	0.00042	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	9.28e-05	0.000419	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—ankylosing spondylitis	9.27e-05	0.000419	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—ankylosing spondylitis	9.25e-05	0.000418	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—ankylosing spondylitis	9.25e-05	0.000417	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—ankylosing spondylitis	9.25e-05	0.000417	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—ankylosing spondylitis	9.25e-05	0.000417	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.25e-05	0.000417	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—ankylosing spondylitis	9.23e-05	0.000417	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—ankylosing spondylitis	9.22e-05	0.000416	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—ankylosing spondylitis	9.15e-05	0.000413	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—ankylosing spondylitis	9.12e-05	0.000412	CcSEcCtD
Doxorubicin—Cough—Methotrexate—ankylosing spondylitis	9.11e-05	0.000411	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—ankylosing spondylitis	9.1e-05	0.000411	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—ankylosing spondylitis	9.04e-05	0.000408	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—ankylosing spondylitis	8.97e-05	0.000405	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—ankylosing spondylitis	8.88e-05	0.000401	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—ankylosing spondylitis	8.88e-05	0.000401	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—ankylosing spondylitis	8.88e-05	0.000401	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—ankylosing spondylitis	8.86e-05	0.0004	CcSEcCtD
Doxorubicin—Rash—Prednisolone—ankylosing spondylitis	8.84e-05	0.000399	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—ankylosing spondylitis	8.83e-05	0.000399	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.82e-05	0.000398	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.8e-05	0.000397	CcSEcCtD
Doxorubicin—TOP2A—tendon—ankylosing spondylitis	8.79e-05	0.0329	CbGeAlD
Doxorubicin—Fatigue—Prednisone—ankylosing spondylitis	8.79e-05	0.000396	CcSEcCtD
Doxorubicin—Headache—Prednisolone—ankylosing spondylitis	8.78e-05	0.000396	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—ankylosing spondylitis	8.78e-05	0.000396	CcSEcCtD
Doxorubicin—Constipation—Prednisone—ankylosing spondylitis	8.71e-05	0.000393	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—ankylosing spondylitis	8.59e-05	0.000388	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—ankylosing spondylitis	8.53e-05	0.000385	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	8.52e-05	0.000384	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—ankylosing spondylitis	8.51e-05	0.000384	CcSEcCtD
Doxorubicin—Infection—Methotrexate—ankylosing spondylitis	8.46e-05	0.000382	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—ankylosing spondylitis	8.4e-05	0.000379	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—ankylosing spondylitis	8.4e-05	0.000379	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—ankylosing spondylitis	8.4e-05	0.000379	CcSEcCtD
Doxorubicin—NQO1—tendon—ankylosing spondylitis	8.38e-05	0.0314	CbGeAlD
Doxorubicin—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.35e-05	0.000377	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	8.34e-05	0.000376	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.33e-05	0.000376	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—ankylosing spondylitis	8.33e-05	0.000376	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—ankylosing spondylitis	8.28e-05	0.000374	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—ankylosing spondylitis	8.28e-05	0.000374	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—ankylosing spondylitis	8.27e-05	0.000373	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	8.23e-05	0.000372	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—ankylosing spondylitis	8.2e-05	0.00037	CcSEcCtD
Doxorubicin—Vomiting—Methylprednisolone—ankylosing spondylitis	8.18e-05	0.000369	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—ankylosing spondylitis	8.13e-05	0.000367	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—ankylosing spondylitis	8.12e-05	0.000367	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—ankylosing spondylitis	8.12e-05	0.000366	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—ankylosing spondylitis	8.11e-05	0.000366	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.11e-05	0.000366	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—ankylosing spondylitis	8.1e-05	0.000365	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—ankylosing spondylitis	8.08e-05	0.000365	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—ankylosing spondylitis	8.06e-05	0.000364	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—ankylosing spondylitis	8.06e-05	0.000364	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—ankylosing spondylitis	8.06e-05	0.000364	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.01e-05	0.000361	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—ankylosing spondylitis	8.01e-05	0.000361	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—ankylosing spondylitis	7.96e-05	0.000359	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.76e-05	0.00035	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—ankylosing spondylitis	7.74e-05	0.000349	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—ankylosing spondylitis	7.74e-05	0.000349	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—ankylosing spondylitis	7.7e-05	0.000348	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—ankylosing spondylitis	7.66e-05	0.000346	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—ankylosing spondylitis	7.65e-05	0.000345	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—ankylosing spondylitis	7.64e-05	0.000345	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—ankylosing spondylitis	7.59e-05	0.000343	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—ankylosing spondylitis	7.57e-05	0.000342	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—ankylosing spondylitis	7.51e-05	0.000339	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—ankylosing spondylitis	7.5e-05	0.000338	CcSEcCtD
Doxorubicin—ABCC10—tendon—ankylosing spondylitis	7.48e-05	0.028	CbGeAlD
Doxorubicin—Vomiting—Dexamethasone—ankylosing spondylitis	7.44e-05	0.000336	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—ankylosing spondylitis	7.44e-05	0.000336	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—ankylosing spondylitis	7.4e-05	0.000334	CcSEcCtD
Doxorubicin—Rash—Betamethasone—ankylosing spondylitis	7.38e-05	0.000333	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—ankylosing spondylitis	7.38e-05	0.000333	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—ankylosing spondylitis	7.37e-05	0.000333	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—ankylosing spondylitis	7.37e-05	0.000333	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.35e-05	0.000332	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—ankylosing spondylitis	7.34e-05	0.000331	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—ankylosing spondylitis	7.33e-05	0.000331	CcSEcCtD
Doxorubicin—Headache—Betamethasone—ankylosing spondylitis	7.33e-05	0.000331	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—ankylosing spondylitis	7.31e-05	0.00033	CcSEcCtD
Doxorubicin—Pain—Methotrexate—ankylosing spondylitis	7.28e-05	0.000329	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—ankylosing spondylitis	7.21e-05	0.000325	CcSEcCtD
Doxorubicin—Feeling abnormal—Methotrexate—ankylosing spondylitis	7.02e-05	0.000317	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—ankylosing spondylitis	6.97e-05	0.000315	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.96e-05	0.000314	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—ankylosing spondylitis	6.95e-05	0.000314	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—ankylosing spondylitis	6.95e-05	0.000314	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—ankylosing spondylitis	6.77e-05	0.000305	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—ankylosing spondylitis	6.74e-05	0.000304	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—ankylosing spondylitis	6.73e-05	0.000304	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—ankylosing spondylitis	6.73e-05	0.000304	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—ankylosing spondylitis	6.48e-05	0.000292	CcSEcCtD
Doxorubicin—Rash—Prednisone—ankylosing spondylitis	6.42e-05	0.00029	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—ankylosing spondylitis	6.42e-05	0.00029	CcSEcCtD
Doxorubicin—Headache—Prednisone—ankylosing spondylitis	6.38e-05	0.000288	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.27e-05	0.000283	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—ankylosing spondylitis	6.11e-05	0.000276	CcSEcCtD
Doxorubicin—Nausea—Prednisone—ankylosing spondylitis	6.05e-05	0.000273	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—ankylosing spondylitis	6.03e-05	0.000272	CcSEcCtD
Doxorubicin—ABCC2—tendon—ankylosing spondylitis	6.01e-05	0.0225	CbGeAlD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	6.01e-05	0.00926	CbGdCrCtD
Doxorubicin—CYP1B1—tendon—ankylosing spondylitis	5.88e-05	0.022	CbGeAlD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	5.86e-05	0.00904	CbGdCrCtD
Doxorubicin—Diarrhoea—Methotrexate—ankylosing spondylitis	5.83e-05	0.000263	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—ankylosing spondylitis	5.63e-05	0.000254	CcSEcCtD
Doxorubicin—Vomiting—Methotrexate—ankylosing spondylitis	5.41e-05	0.000244	CcSEcCtD
Doxorubicin—Rash—Methotrexate—ankylosing spondylitis	5.37e-05	0.000242	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—ankylosing spondylitis	5.36e-05	0.000242	CcSEcCtD
Doxorubicin—Headache—Methotrexate—ankylosing spondylitis	5.33e-05	0.000241	CcSEcCtD
Doxorubicin—ABCC1—tendon—ankylosing spondylitis	5.29e-05	0.0198	CbGeAlD
Doxorubicin—Nausea—Methotrexate—ankylosing spondylitis	5.06e-05	0.000228	CcSEcCtD
